Nymox Pharmaceutical
NYMX
#9679
Rank
NZ$31.27 M
Marketcap
Country
$0.34
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Nymox Pharmaceutical (NYMX)

EPS in 2023 (TTM): -$0.09896

According to Nymox Pharmaceutical's latest financial reports the company's current EPS (TTM) is -$0.10. In 2022 the company made an earnings per share (EPS) of -$0.14 an increase over its 2021 EPS that were of -$0.26.

EPS history for Nymox Pharmaceutical from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.09896-27.81%
2022-$0.14-46.67%
2021-$0.26-11.76%
2020-$0.29-15%
2019-$0.345.26%
2018-$0.33-26.92%
2017-$0.45-7.14%
2016-$0.48-40.43%
2015-$0.81291.67%
2014-$0.21-7.69%
2013-$0.22-43.48%
2012-$0.39-25.81%
2011-$0.5355%
2010-$0.3425%
2009-$0.270.08%
2008-$0.27-11.12%
2007-$0.31-0.16%
2006-$0.3128.59%
2005-$0.24-12.49%
2004-$0.27-16.05%
2003-$0.3319.07%
2002-$0.2714.45%
2001-$0.24-22.16%
2000-$0.315.64%
1999-$0.29-34.59%
1998-$0.45-3.6%
1997-$0.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$5.09-5,053.67%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.19-3,200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$11.58-11,366.67%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.30-9,148.82%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.14-23,575.50%๐Ÿ‡บ๐Ÿ‡ธ USA